These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 20099191

  • 21. Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy.
    Brooks JD, Ward WE, Lewis JE, Hilditch J, Nickell L, Wong E, Thompson LU.
    Am J Clin Nutr; 2004 Feb; 79(2):318-25. PubMed ID: 14749240
    [Abstract] [Full Text] [Related]

  • 22. A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.
    Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, Pike MC.
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):601-5. PubMed ID: 9168002
    [Abstract] [Full Text] [Related]

  • 23. Effect of energy deficiency on estrogen metabolism in premenopausal women.
    Westerlind KC, Williams NI.
    Med Sci Sports Exerc; 2007 Jul; 39(7):1090-7. PubMed ID: 17596776
    [Abstract] [Full Text] [Related]

  • 24. The ratio of the estradiol metabolites 2-hydroxyestrone (2-OHE1) and 16α-hydroxyestrone (16-OHE1) may predict breast cancer risk in postmenopausal but not in premenopausal women: two case-control studies.
    Ruan X, Seeger H, Wallwiener D, Huober J, Mueck AO.
    Arch Gynecol Obstet; 2015 May; 291(5):1141-6. PubMed ID: 25318606
    [Abstract] [Full Text] [Related]

  • 25. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women.
    Ursin G, London S, Yang D, Tseng CC, Pike MC, Bernstein L, Stanczyk FZ, Gentzschein E.
    Breast Cancer Res Treat; 2002 Mar; 72(2):139-43. PubMed ID: 12038704
    [Abstract] [Full Text] [Related]

  • 26. Effect of dietary soy isoflavone aglycones on the urinary 16alpha-to-2-hydroxyestrone ratio in C3H/HeJ mice.
    Kishida T, Beppu M, Nashiki K, Izumi T, Ebihara K.
    Nutr Cancer; 2000 Mar; 38(2):209-14. PubMed ID: 11525599
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Flaxseed consumption influences endogenous hormone concentrations in postmenopausal women.
    Hutchins AM, Martini MC, Olson BA, Thomas W, Slavin JL.
    Nutr Cancer; 2001 Mar; 39(1):58-65. PubMed ID: 11588903
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effect of Dietary Flaxseed Intake on Circulating Sex Hormone Levels among Postmenopausal Women: A Randomized Controlled Intervention Trial.
    Chang VC, Cotterchio M, Boucher BA, Jenkins DJA, Mirea L, McCann SE, Thompson LU.
    Nutr Cancer; 2019 Mar; 71(3):385-398. PubMed ID: 30375890
    [Abstract] [Full Text] [Related]

  • 31. Influence of postmenopausal hormone replacement therapy on an estrogen metabolite biomarker of risk for breast cancer.
    Alvarez-Vasquez RB, Axelrod D, Frenkel K, Newman MC, Sepkovic DW, Bradlow HL, Zumoff B.
    Horm Metab Res; 2003 Jun; 35(6):358-61. PubMed ID: 12920658
    [Abstract] [Full Text] [Related]

  • 32. Urinary estrogen metabolites and breast cancer: a combined analysis of individual level data.
    Dallal CM, Stone RA, Cauley JA, Ness RB, Vogel VG, Fentiman IS, Fowke JH, Krogh V, Loft S, Meilahn EN, Muti P, Olsen A, Overvad K, Sieri S, Tjønneland A, Ursin G, Wellejus A, Taioli E.
    Int J Biol Markers; 2013 Apr 23; 28(1):3-16. PubMed ID: 22865302
    [Abstract] [Full Text] [Related]

  • 33. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women.
    Xu X, Duncan AM, Merz BE, Kurzer MS.
    Cancer Epidemiol Biomarkers Prev; 1998 Dec 23; 7(12):1101-8. PubMed ID: 9865428
    [Abstract] [Full Text] [Related]

  • 34. Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer.
    Greenlee H, Chen Y, Kabat GC, Wang Q, Kibriya MG, Gurvich I, Sepkovic DW, Bradlow HL, Senie RT, Santella RM, Ahsan H.
    Breast Cancer Res Treat; 2007 Mar 23; 102(1):111-7. PubMed ID: 16850246
    [Abstract] [Full Text] [Related]

  • 35. Estradiol metabolism during oral and transdermal estradiol replacement therapy in postmenopausal women.
    Lippert TH, Seeger H, Mueck AO.
    Horm Metab Res; 1998 Sep 23; 30(9):598-600. PubMed ID: 9808331
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Estrogen metabolism as a risk factor for head and neck cancer.
    Yoo HJ, Sepkovic DW, Bradlow HL, Yu GP, Sirilian HV, Schantz SP.
    Otolaryngol Head Neck Surg; 2001 Mar 23; 124(3):241-7. PubMed ID: 11240983
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Estrogen metabolism and the diet-cancer connection: rationale for assessing the ratio of urinary hydroxylated estrogen metabolites.
    Lord RS, Bongiovanni B, Bralley JA.
    Altern Med Rev; 2002 Apr 23; 7(2):112-29. PubMed ID: 11991791
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.